ReviewFrontiers in immunology2020

Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade.

Yu-Chen Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.